Target intelligence / Profile preview

Olfactory receptor family 5 subfamily AP member 2 (OR5AP2)

Target
OR5AP2
Molecular classification
G protein-coupled receptor, Receptor, Olfactory receptor
01

Overview

Olfactory receptor family 5 subfamily AP member 2 (OR5AP2) is a member of the olfactory receptor gene family in humans. These receptors are G protein-coupled receptors (GPCRs) that detect odorant molecules in the nasal epithelium, triggering signal transduction pathways that result in the perception of smell. OR5AP2 binds to specific odorants, activating intracellular G proteins and promoting the production of cAMP, which subsequently opens ion channels and initiates an action potential in olfactory sensory neurons. Like other olfactory receptors, it has a seven-transmembrane domain structure and is predominantly expressed in the olfactory epithelium. Some reports also associate this receptor with pathways in non-olfactory tissues and mention a possible role in diseases such as ovarian cancer, but no direct mechanistic or therapeutic link has been established.

Other names
Olfactory receptor 5AP2OR9J1Olfactory receptor, family 9, subfamily J, member 1
02

Mechanism of action

Ligand (odorant) binds receptor, activating G protein-coupled signaling pathways, leading to cAMP production, ion channel opening, neuronal depolarization, and signal transmission to the brain. No characterized pharmacological modulators or inhibitors

03

Biological functions

Odorant recognition and bindingSignal transduction via G protein-coupled mechanismsInitiation of neuronal response triggering perception of smell
04

Disease associations

Cancer (association reported, e.g., ovarian cancer)Other (possible—roles in non-olfactory tissues, but direct disease involvement unconfirmed)
05

Safety considerations

No established safety concerns or therapeutic challenges specific to OR5AP2, as it is not currently a therapeutic drug target; olfactory receptor modulation in non-olfactory tissues remains a field of research interest but without established safety data
06

Interacting drugs

None known or characterized in the public literature as of now; olfactory receptors generally bind odorant ligands rather than conventional drugs
07

Biomarkers

None identified specifically for OR5AP2 in terms of patient selection or efficacy monitoring

Beyond the preview

Go deeper on Olfactory receptor family 5 subfamily AP member 2 (OR5AP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Olfactory receptor family 5 subfamily AP member 2 (OR5AP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call